Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nancy M Holekamp

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
JAMA Ophthalmology|March 6, 2025
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical TrialDante J Pieramici, Carl C Awh, Margaret Chang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 15, 2009
The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship to the etiology of nuclear cataractsYing-Bo Shui, Nancy M Holekamp, Benjamin C Kramer, et al.
American Journal of Ophthalmology|March 7, 2008
Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosisRamin Schadlu, Kevin J Blinder, Gaurav K Shah, et al.
Journal of Clinical Medicine|April 3, 2021
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular DegenerationAllen C Ho, Jeffrey S Heier, Nancy M Holekamp, et al.
Ophthalmology|October 1, 2021
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular DegenerationNancy M Holekamp, Peter A Campochiaro, Margaret A Chang, et al.
Ophthalmology Science|January 15, 2025
Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence AnalyticsEric W Schneider, Jeffrey S Heier, Nancy M Holekamp, et al.
Ophthalmology Science|October 17, 2022
A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic AtrophyArshad M Khanani, Raj K Maturi, Nika Bagheri, et al.
Retina (Philadelphia, Pa.)|March 7, 2024
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel GuidanceCharles C Wykoff, Robert L Avery, Mark R Barakat, et al.
Journal of Vitreoretinal Diseases|December 10, 2024
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular DegenerationJeffrey S Heier, Yingna Liu, Nancy M Holekamp, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
JAMA Ophthalmology|March 6, 2025
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical TrialDante J Pieramici, Carl C Awh, Margaret Chang, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 15, 2009
The gel state of the vitreous and ascorbate-dependent oxygen consumption: relationship to the etiology of nuclear cataractsYing-Bo Shui, Nancy M Holekamp, Benjamin C Kramer, et al.
American Journal of Ophthalmology|March 7, 2008
Intravitreal bevacizumab for choroidal neovascularization in ocular histoplasmosisRamin Schadlu, Kevin J Blinder, Gaurav K Shah, et al.
Journal of Clinical Medicine|April 3, 2021
Real-World Performance of a Self-Operated Home Monitoring System for Early Detection of Neovascular Age-Related Macular DegenerationAllen C Ho, Jeffrey S Heier, Nancy M Holekamp, et al.
Ophthalmology|October 1, 2021
Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular DegenerationNancy M Holekamp, Peter A Campochiaro, Margaret A Chang, et al.
Ophthalmology Science|January 15, 2025
Pivotal Trial Toward Effectiveness of Self-administered OCT in Neovascular Age-related Macular Degeneration. Report 2-Artificial Intelligence AnalyticsEric W Schneider, Jeffrey S Heier, Nancy M Holekamp, et al.
Ophthalmology Science|October 17, 2022
A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic AtrophyArshad M Khanani, Raj K Maturi, Nika Bagheri, et al.
Retina (Philadelphia, Pa.)|March 7, 2024
SUPRACHOROIDAL SPACE INJECTION TECHNIQUE: Expert Panel GuidanceCharles C Wykoff, Robert L Avery, Mark R Barakat, et al.
Journal of Vitreoretinal Diseases|December 10, 2024
Clinical Use of Home OCT Data to Manage Neovascular Age-Related Macular DegenerationJeffrey S Heier, Yingna Liu, Nancy M Holekamp, et al.
Pageof 7